drugset / Trial / NCT00596622

FMRI Study of Brain Response Before and After Lithium Treatment in People With Bipolar Disorder

NCT00596622

Non-randomizedSingle-groupOpen-labelDiagnostic

Summary

This study will assess the effects of bipolar disorder on brain activity and will determine if medication changes the brain activity in people with bipolar disorder.

Timeline

Start
2007-08
Primary completion
2012-01
Completion
2012-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Lithium Unknown 1200 mg

Indications